Adrenal incidentaloma

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 10, 2000, Pages 1177-1189

  Arnaldi, G ^a   Masini, A M ^a   Giacchetti, C ^a   Taccaliti, A ^a   Faloia, E ^a   Mantero, F ^a,b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

Author keywords

Adrenal incidentaloma; Aldosterone producing adenoma; Silent pheochromocytoma; Subclinical Cushing's syndrome

Indexed keywords

ADENOMA; ADRENAL TUMOR; CUSHING SYNDROME; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPERALDOSTERONISM; INCIDENCE; MALE; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; REVIEW;

ADENOMA; ADRENAL GLAND NEOPLASMS; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERALDOSTERONISM; INCIDENCE; MALE; PHEOCHROMOCYTOMA;

EID: 0034293156     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000001000007     Document Type: Article

References (35)

1. Chidiac RM & Aron DC (1997). Incidentalomas. A disease of modern technology. Endocrinology and Metabolism Clinics of North America, 26: 233-253.
2. Griffing G (1994). A-I-D-S: The new endocrine epidemic [Editorial comment]. Journal of Clinical Endocrinology and Metabolism, 79: 1530-1531.
3. Kloos RT, Gross MD, Francis IR, Korobkin M & Shapiro B (1995). Incidentally discovered adrenal masses. Endocrine Reviews, 16: 460-484.
4. Mantero F & Arnaldi G (1999). Investigation protocol: adrenal enlargement. Clinical Endocrinology, 50: 141-146.
5. Turner HE, Moore NR, Byrne JV & Wass JAH (1998). Pituitary, adrenal and thyroid incidentalomas. Endocrine-Related Cancer, 5: 131-150.
6. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G & Angeli A (2000). On behalf of the Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism, 85: 637-644.
7. Bornstein SR, Stratakis CA & Chrousos GP (1999). Adrenocortical tumors: recent advances in basic concepts and clinical management. Annals of Internal Medicine, 130: 759-771.
8. Schulick RD & Brennan MF (1999). Adrenocortical carcinoma. World Journal of Urology, 17: 25-34.
9. Kasperlik-Zaluska AA, Rostonowskaa E, Stowinska-Srzednicka J, Midgalska B, Jeske W, Mkowska A & Snochowska H (1997). Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clinical Endocrinology, 46: 29-37.
10. Peppercorn PD, Grossman AB & Reznek RH (1998). Imaging of incidentally discovered adrenal masses. Clinical Endocrinology, 48: 379-388.
11. Pender SM, Boland GW & Lee MJ (1998). The incidental nonhyperfunctioning adrenal mass: an imaging algorithm for characterization. Clinical Radiology, 53: 796-804.
12. Welch TJ, Sheedy PF, Stephens DH, Johnson CM & Swensen SJ (1994). Percutaneous adrenal biopsy: review of a 10-year experience. Radiology, 193: 341-344.
13. Silverman SG, Mueller PR, Pinkney LP, Koenker RM & Seltzer SE (1993). Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology, 187: 715-718.
14. Falke THM & Sandler MP (1994). Classification of silent adrenal masses: time to get practical. Journal of Nuclear Medicine, 35: 1152-1153.
15. Dwamena BA, Kloos RT, Fendrick MA, Gross MD, Francis IR, Korobkin MT & Shapiro B (1998). Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses. Journal of Nuclear Medicine, 39: 707-712.
16. Bardet S, Rohmer V, Murat A, Guillemot C, Marechaud R, Chupin M, Lecomte P, Simon D, Delemer B, Schneebelli S, Beutter D, Jacquin V, Peltier P, Charbonnel B & West France Study Group on Incidentalomas (WFSGI) (1996). 131 - 6ß-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clinical Endocrinology, 44: 587-596.
17. Erasmus JJ, Patz Jr EF, McAdams HP, Murray JG, Herndon J, Coleman RE & Goodman PC (1997). Evaluation of adrenal masses n patients with bronchogenic carcinoma using 18F-fluorodeoxy-glucose positron emission tomography. American Journal of Roentgenology, 168: 1357-1360.
18. Ambrosi B, Peverelli S, Passini E, Re T, Ferrano R, Colombo P, Sartorio A & Faglia G (1995). Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. European Journal of Endocrinology, 132: 422-428.
19. Terzolo M, Osella G, Ali A, Borretta G, Cesario F, Paccotti P & Angei A (1998). Subclinical Cushing's syndrome in adrenal incidentaloma. Clinical Endocrinology, 48: 89-97.
20. Aron DC (1998). Adrenal incidentalomas and glucocorticoid autonomy (Commentary). Clinical Endocrinology, 49: 157-158.
21. Lavoie H & Lacroix A (1995). Partially autonomous cortisol secretion by incidentally discovered adrenal adenomas. Trends in Endocrinology and Metabolism, 6: 191-194.
22. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A & Boscaro M (1999). Risk factors and long-term follow-up of adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism, 84: 520-526.
23. Osella G, Terzolo M, Borretta G, Magro G, Ali A, Piovesan A, Paccotti P & Angeli A (1994). Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). Journal of Clinical Endocrinology and Metabolism, 79: 1532-1539.
24. Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cammisa M, Modoni S, Carnevale V, Trischitta V & Scillitani A (1999). Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. Journal of Clinical Endocrinology and Metabolism, 84: 2381-2385.
25. Jaresch S, Kornely E, Kley HK & Schlaghecke R (1992). Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 74: 685-689.
26. Kjellman M, Holst M, Backdahl M, Larsson C, Farnebo LO & Wedell A (1999). No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours. Clinical Endocrinology, 50: 343-346
27. Beuschlein F, Schulze E, Moro P, Gensheimer HP, Maser-Gluth C, Allolio B & Reincke M (1998). Steroid 21-hydroxylase mutations and 21-hydroxylase mRNA expression in human adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 83: 2585-2588.
28. Bencsik Z, Szabolks I, Kovaks Z, Ferencz A, Voros A, Kaszas I, Bor K, Gonczi J, Goth M, Kovacs L, Dohan O & Szilagy G (1996). Low dehydroepiandrosterone sulfate (DHEAS) level is not a good predictor of hormona: activity in nonselected patients with incidentally detected adrenal tumours. Journal of Clinical Endocrinology and Metabolism, 81: 1726-1729.
29. Gordon RD, Klemm SA, Stowasser M, Tunny TJ, Stone WJ & Rutherord JC (1993). How common is primary aldosteronism? Is it the most frequent cause of curable hypertension? Journal of Hypertension, 11 (Suppl 5): S310-S311.
30. Biglieri EG, Kater CE & Vlantero F (1995). Adrenocortical forms of human hypertension. In: Laragh JH & Brenner BM (Editors), Hypertension Pathophysiology, Diagnosis and Management. 2nd edn. Raven Press, New York, 2145-2162.
31. Gordon RD (1995). Primary aldosteronism. Journal of Endocrinological Investigation, 18: 495-511.
32. Bravo EL (1994). Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocrine Reviews, 15: 356-368.
33. Sutton MG, Sheps SG & Lie JT (1981). Prevalence of clinically unsuspected pheochromocytoma: a review of a 50-years autopsy series. Mayo Clinic Proceedings, 56: 354-360.
34. Lenders JW, Keiser HR, Goldstein DS, Willemsen BS, Friberg P, Jacobs MC, Kloppenborg PW, Thien T & Eisenhofer G (1995). Plasma metanephrines in the diagnosis of pheochromocytoma. Annals of Internal Medicine, 123: 101-109.
35. Wells SA, Merke DP, Cutler Jr GB, Norton JA & Lacroix A (1998). The role of laparoscopic surgery in adrenal disease. Journal of Clinical Endocrinology and Metabolism, 83: 3041-3049.